Relationship Between Autonomic Nervous System Activity and Recurrence After Cryoballoon Ablation in Patients with Paroxysmal Atrial Fibrillation

Abstract

Introduction: In this study, we aimed to investigate the relationship between autonomic dysfunction (AD) determined according to the blood pressure (BP) and heart rate (HR) response in exercise treadmill test (ETT) prior to cryoballoon ablation (CBA), and the recurrence of atrial fibrillation (AF) after CBA in patients with paroxysmal AF. Patients and Methods: Seventy-six patients (mean age 53 ± 11 years, 61.8% male) with paroxysmal AF who underwent CBA were enrolled. Before CBA the ETT was performed by all patients. BP and HR responses in ETT were compared between patients with and without AF recurrence. Results: AD rate was significantly higher in the group with recurrence compared to the non-recurrent group (p< 0.001). In addition to AD, age, female gender, and lower exercise capacity were also associated with post-CBA AF recurrence (p> 0.05 for all). Examining AD parameters, systolic blood pressure at peak exercise (SBPpeak) (p< 0.001) and diastolic blood pressure at peak exercise (DBPpeak) (p< 0.001), slow heart rate recovery (HRR) (p< 0.001) were significantly higher in the recurrent group. Conclusion: AD may be associated with AF recurrence after CBA in patients with paroxysmal AF. SBPpeak, DBPpeak, and slow HRR appear to be predictors of AF recurrence after ablation.

Keywords

• Atrial fibrillation
• autonomic nervous system
• catheter ablation

References

1. 1. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation. analysis and implications. Arch Intern Med 1995;155(5):469-73. [Crossref]
2. 2. Kopecky SL, Gersh BJ, McGoon MD, Whisnant JP, Holmes Jr DR, Ilstrup DM, et al. The natural history of lone atrial fibrillation. A population-based study over three decades. N Engl J Med 1987;317(11):669-74. [Crossref]
3. 3. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation-executive summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). Eur Heart J 2006;27(16):1979-2030. [Crossref]
4. 4. European Heart Rhythm Association (EHRA); European Cardiac Arrhythmia Scoiety (ECAS); American College of Cardiology (ACC); American Heart Association (AHA); Society of Thoracic Surgeons (STS), Calkins H, et al. HRS/EHRA/ECAS Expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the heart rhythm society (HRS) task force on catheter and surgical ablation of atrial fibrillation. Heart Rhythm 2007;4(6):816-61.
5. 5. Kojodjojo P, O’Neill MD, Lim PB, Malcolm-Lawes L, Whinnett ZI, Salukhe TV, et al. Pulmonary venous isolation by antral ablation with a large cryoballoon for treatment of paroxysmal and persistent atrial fibrillation: medium-term outcomes and non-randomised comparison with pulmonary venous isolation by radiofrequency ablation. Heart 2010;96(17):1379-84. [Crossref]
6. 6. Mandell J, Amico F, Parekh S, Snow J, Germano J, Cohen TJ. Early experience with the cryoablation balloon procedure for the treatment of atrial fibrillation by an experienced radiofrequency catheter ablation center. J Invasive Cardiol 2013;25(6):288-92.
7. 7. Defaye P, Kane A, Chaib A, Jacon P. Efficacy and safety of pulmonary veins isolation by cryoablation for the treatment of paroxysmal and persistent atrial fibrillation. Europace 2011;13(6):789-95. [Crossref]
8. 8. Coumel P, Attuel P, Leclercq JF, Friocourt P. Atrial arrhythmias of vagal or catecholaminergic origin: comparative effects of beta-blocker treatment and the escape phenomenon. Arch Mal Coeur Vaiss 1982;75(4):373-87.

9. 9. Coumel P. Clinical approach to paroxysmal atrial fibrillation. Clin Cardiol 1990;13(3):209-12 [Crossref]
10. 10. Fioranelli M, Piccoli M, Mileto GM, Sgreccia F, Azzolini P, Risa MP et al. Analysis of heart rate variability five minutes before the onset of paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 1999;22(5):743-9. [Crossref]
11. 11. Hnatkova K, Waktare JE, Sopher SM, Murgatroyd FD, Baiyan X, Camm AJ et al. A relationship between fluctuations in heart rate and the duration of subsequent episodes of atrial fibrillation. Pacing Clin Electrophysiol 1998;21(1 Pt 2):181-5 [Crossref]
12. 12. Zimmermann M, Kalusche D. Fluctuation in autonomic tone is a major determinant of sustained atrial arrhythmias in patients with focal ectopy originating from the pulmonary veins. J Cardiovasc Electrophysiol 2001;12(3):285-91. [Crossref]
13. 13. Miyai N, Arita M, Morioka I, Takeda S, Miyashita K. Ambulatory blood pressure, sympathetic activity, and left ventricular structure and function in middle-aged normotensive men with exaggerated blood pressure response to exercise. Med Sci Monit 2005;11(10):CR478-84.
14. 14. Eryonucu B, Bilge M, Güler N, Uygan I. The effect of autonomic nervous system activity on exaggerated blood pressure response to exercise: evaluation by heart rate variability. Acta Cardiol 2000;55(3):181-5. [Crossref]
15. 15. Kulics JM, Collins HL, DiCarlo SE. Postexercise hypotension is mediated by reductions in sympathetic nerve activity. Am J Physiol 1999;276(1):H27-32. [Crossref]
16. 16. Casonatto J, Polito MD. Post-exercise hypotension: a systematic review. Rev Bras Med Esporte 2009;15(2):151-7. [Crossref]
17. 17. Kannankeril PJ, Le FK, Kadish AH, Goldberger JJ. Parasympathetic effects on heart rate recovery after exercise. J Investig Med 2004;52(6):394-401. [Crossref]
18. 18. Buchheit M, Papelier Y, Laursen PB, Ahmaidi S. Noninvasive assessment of cardiac parasympathetic function: postexercise heart rate recovery or heart rate variability? Am J Physiol Heart Circ Physiol 2007;293(1):H8-10. [Crossref]
19. 19. Bruce RA, Kusumi F, Hosmer D. Maximal oxygen intake and nomographic assessment of functional aerobic impairment in cardiovascular disease. Am Heart J 1973;85(4):546-62. [Crossref]
20. 20. Gibbons RJ, Balady GJ, Beasley JW, Bricker JT, Duvernoy WF, Froelicher VF, et al. ACC/AHA guidelines for exercise testing. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). J Am Coll Cardiol 1997;30(1):260-311. [Crossref]
21. 21. Oldershaw P. Stress testing: principles and practice: ed III. Int J Cardiol 1987;14(1):117. [Crossref]
22. 22. Fletcher GF, Ades PA, Kligfield P, Arena R, Balady GJ, Bittner VA, et al; American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee of the Council on Clinical Cardiology, Council on Nutrition, Physical Activity and Metabolism, Council on Cardiovascular and Stroke Nursing, and Council on Epidemiology and Prevention. Exercise standards for testing and training: a scientific statement from the American Heart Association. Circulation 2013;128(8):873-934. [Crossref]
23. 23. American College of Sports Medicine. Guidelines for exercise testing and prescription. 9th ed. Lippincott: Williams & Wilkins; 2013.
24. 24. Nishime EO, Cole CR, Blackstone EH, Pashkow FJ, Lauer MS. Heart rate recovery and treadmill exercise score as predictors of mortality in patients referred for exercise ECG. JAMA 2000;284(11):1392-8. [Crossref]
25. 25. Vivekananthan DP, Blackstone EH, Pothier CE, Lauer MS. Heart rate recovery after exercise is a predictor of mortality, independent of the angiographic severity of coronary disease. J Am Coll Cardiol 2003;42(5):831-8. [Crossref]
26. 26. Gera N, Taillon LA, Ward RP. Usefulness of abnormal heart rate recovery on exercise stress testing to predict high-risk findings on single-photon emission computed tomography myocardial perfusion imaging in men. Am J Cardiol 2009;103(5):611-4. [Crossref]
27. 27. Neumann T, Vogt J, Schumacher B, Dorszewski A, Kuniss M, Neuser H, et al. Circumferential pulmonary vein isolation with the cryoballoon technique results from a prospective 3-center study. J Am Coll Cardiol 2008;52(4):273-8. [Crossref]
28. 28. Van Belle Y, Janse P, Rivero-Ayerza MJ, Thornton AS, Jessurun ER, Theuns D, et al. Pulmonary vein isolation using an occluding cryoballoon for circumferential ablation: feasibility, complications, and short-term outcome. Eur Heart J 2007;28(18):2231-7. [Crossref]
29. 29. Chen YJ, Chen SA, Tai CT, Wen ZC, Feng AN, Ding YA, et al. Role of atrial electrophysiology and autonomic nervous system in patients with supraventricular tachycardia and paroxysmal atrial fibrillation. J Am Coll Cardiol 1998;32(3):732-8. [Crossref]
30. 30. Lele SS, Scalia G, Thomson H, Macfarlane D, Wilkinson D, Stafford W, et al. Mechanism of exercise hypotension in patients with ischemic heart disease. Role of neurocardiogenically mediated vasodilation. Circulation 1994;90:2701e2709. [Crossref]
31. 31. Dimmer C, Tavernier R, Gjorgov N, Van Nooten G, Clement DL, Jordaens L. Variations of autonomic tone preceding onset of atrial fibrillation after coronary artery bypass grafting. Am J Cardiol 1998;82(1):22-5. [Crossref]
32. 32. Wen ZC, Chen SA, Tai CT, Huang JL, Chang MS. Role of autonomic tone in facilitating spontaneous onset of typical atrial flutter. J Am Coll Cardiol 1998;31(3):602-7. [Crossref]
33. 33. Coccagna G, Capucci A, Bauleo S, Boriani G, Santarelli A. Paroxysmal atrial fibrillation in sleep. Sleep 1997;20:396-8. [Crossref]
34. 34. Klingenheben T, Grönefeld G, Li YG, Hohnloser SH. Heart rate variability to assess changes in cardiac vagal modulation before the onset of paroxysmal atrial fibrillation in patients with and without structural heart disease. Ann Noninvas Electrocardiol 1999;4:19-26. [Crossref]
35. 35. Herweg B, Dalal P, Nagy B, Schweitzer P. Power spectral analysis of heart period variability of preceding sinus rhythm before initiation of paroxysmal atrial fibrillation. Am J Cardiol 1998;82:869-74. [Crossref]
36. 36. O’Neal WT, Qureshi WT, Blaha MJ, Ehrman JK, Brawner CA, Nasir K, et al. Relation of risk of atrial fibrillation with systolic blood pressure response during exercise stress testing (from the henry ford exercise testing project). Am J Cardiol 2015;116(12):1858-62. [Crossref]
37. 37. Fioranelli M, Piccoli M, Mileto GM, Sgreccia F, Azzolini P, Risa MP, et al Analysis of heart rate variability five minutes before the onset of paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 1999;22:743-9. [Crossref]
38. 38. Kanda S, Amino M, Sakama S, Ayabe K, Sakai T, Nagamatsu H, et al. Relation between autonomic nervous activity after pulmonary vein isolation and recurrence in paroxysmal atrial fibrillation patients. Tokai J Exp Clin Med 2018;43(4):153-60.
39. 39. Kuyumcu MS, Ozeke O, Cay S, Ozcan F, Bayraktar MF, Kara M, et al. The short-term impact of the catheter ablation on noninvasive autonomic nervous system parameters in patients with paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 2017;40(11):1193-9. [Crossref]
40. 40. Gardner E, O’Rahilly R. The nerve supply and conducting system of the human heart at the end of the embryonic period proper. J Anat 1976;121:571-87.
41. 41. Chen PS, Chen LS, Fishbein MC, Lin SF, Nattel S. Role of the autonomic nervous system in atrial fibrillation: pathophysiology and therapy. Circ Res 2014;114(9):1500-15. [Crossref]
42. 42. Santangeli P, Lin D. Catheter ablation of paroxysmal atrial fibrillation: have we achieved cure with pulmonary vein isolation? Methodist Debakey Cardiovasc J 2015;11(2):71-5. [Crossref]
43. 43. Bayés de Luna A, Bayés Genís A, Guindo J, Viñolas X, Boveda S, Torner P, et al. Mechaniss favoring and triggering atrial fibrillation. Arch Mal Coeur 1994;87:19-25.
44. 44. Holmqvist L, Mortensen L, Kanckos C, Ljungman C, Mehlig K, Manhem K. Exercise blood pressure and the risk of future hypertension. J Hum Hypertens 2012; 26:691-5. [Crossref]
45. 45. Laukkanen JA, Kurl S. Blood pressure responses during exercise testing-is up best for prognosis?. Ann Med 2012;44:218-24. [Crossref]
46. 46. Kayrak M, Bacaksiz A, Vatankulu MA, Ayhan SS, Kaya Z, Ari H et al. Exaggerated blood pressure response to exercise-a new portent of masked hypertension. Clin Exp Hypertens 2010;32:560-8. [Crossref]
47. 47. Schultz MG, Hare JL, Marwick TH, Stowasser M, Sharman JE. Masked hypertension is ‘unmasked’ by low-intensity exercise blood pressure. Blood Press 2011;20:284-9. [Crossref]
48. 48. Thanassoulis G, Lyass A, Benjamin EJ, Larson MG, Vita JA, Levy D, et al. Relations of exercise blood pressure response to cardiovascular risk factors and vascular function in the framingham heart study. Circulation 2012;125(23):2836-43. [Crossref]
49. 49. Sung J, Choi SH, Choi YH, Kim DK, Park WH. The relationship between arterial stiffness and increase in blood pressure during exercise in normotensive persons. J Hypertens 2012;30:587-91. [Crossref]
50. 50. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997;96(4):1180-4. [Crossref]
51. 51. Jaïs P, Peng JT, Shah DC, Garrigue S, Hocini M, Yamane T, et al. Left ventricular diastolic dysfunction in patients with so-called lone atrial fibrillation. J Cardiovasc Electrophysiol 2000;11(6):623-5. [Crossref]
52. 52. Chung MK, Martin DO, Sprecher D, Wazni O, Kanderian A, Carnes CA, et al. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2001;104(24):2886-91. [Crossref]
53. 53. Skalidis EI, Hamilos MI, Karalis IK, Chlouverakis G, Kochiadakis GE, Vardas PE. Isolated atrial microvascular dysfunction in patients with lone recurrent atrial fibrillation. J Am Coll Cardiol 2008;51(21):2053-7. [Crossref]